Development Level

Tbio 4 | 10,625
Tdark 1 | 7,003

IMPC Term

immune system phenotype 1 | 17

Disease

glioblastoma 4 | 5,572
osteosarcoma 4 | 7,933
pediatric high grade glioma 4 | 2,712
pilocytic astrocytoma 4 | 3,086
medulloblastoma, large-cell 3 | 6,234
ovarian cancer 3 | 8,484
Alzheimer's disease 2 | 644
Anxiety Disorders 2 | 37
Cancer 2 | 2,346
Hypotension 2 | 53
Pick disease 2 | 1,893
astrocytoma 2 | 1,493
atypical teratoid / rhabdoid tumor 2 | 4,369
chronic kidney disease 2 | 90
ependymoma 2 | 2,514
oligodendroglioma 2 | 2,849
posterior fossa group A ependymoma 2 | 1,511
primitive neuroectodermal tumor 2 | 3,031
sonic hedgehog group medulloblastoma 2 | 1,482
Acromegaly 1 | 40
Addison's disease 1 | 29
Adenoma 1 | 165
Adrenal adenoma 1 | 5
Alcohol dependence 1 | 107
Alopecia 1 | 55
Amenorrhea 1 | 60
Anorexia 1 | 15
Anorexia nervosa 1 | 59
Anxiety disorder 1 | 22
Atypical depressive disorder 1 | 6
Bipolar Disorder 1 | 266
Bradycardia 1 | 24
Carcinoma 1 | 2,147
Cerebrovascular disease 1 | 231
Chondroma 1 | 12
Chronic fatigue syndrome 1 | 29
Cocaine-Related Disorders 1 | 88
Cognition Disorders 1 | 23
Cornelia de Lange syndrome 1 | 21
Cushing Syndrome 1 | 3
Cushing's syndrome 1 | 47
Depressive disorder 1 | 48
Diabetes insipidus 1 | 14
Down syndrome 1 | 548
End Stage Liver Disease 1 | 4
Epilepsy 1 | 346
Fever 1 | 34
Fibromyalgia 1 | 22
Fibrosarcoma 1 | 12
Generalized anxiety disorder 1 | 29
Hepatic encephalopathy 1 | 25
Hypertension 1 | 287
Hypertensive disease 1 | 193
Hypoglycemia 1 | 81
Hypopituitarism 1 | 36
Hypothyroidism 1 | 89
Inflammation 1 | 109
Irritable bowel syndrome 1 | 59
Liposarcoma 1 | 20
Major Depressive Disorder 1 | 106
Malignant fibroxanthoma 1 | 8
Melancholia 1 | 12
Movement Disorders 1 | 21
Multiple Sclerosis 1 | 498
Nelson syndrome 1 | 6
Neurohypophyseal diabetes insipidus 1 | 13
Nonsyndromic deafness 1 | 121
Ovarian mucinous cystadenocarcinoma 1 | 2
Pain 1 | 70
Pain agnosia 1 | 99
Panic disorder 1 | 55
Peripheral Neuropathy 1 | 303
Pituitary adenoma 1 | 35
Pontocerebellar hypoplasia 1 | 29
Psychomotor Disorders 1 | 7
Retinitis 1 | 9
Sarcoma 1 | 49
Schizophrenia 1 | 501
Seizures 1 | 95
Sensorineural hearing loss 1 | 107
Status Epilepticus 1 | 85
Stereotypic movement disorder 1 | 6
Substance Withdrawal Syndrome 1 | 52
Substance abuse 1 | 55
Toxic encephalopathy 1 | 131
Vascular disease 1 | 281
Waldenstrons macroglobulinemia 1 | 765
Weight decreased 1 | 18
West Syndrome 1 | 23
Withdrawal disorder 1 | 19
adult high grade glioma 1 | 2,148
aldosterone-producing adenoma 1 | 664
atypical teratoid/rhabdoid tumor 1 | 1,095
diabetes mellitus 1 | 1,663
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
medulloblastoma 1 | 1,524
pancreatic cancer 1 | 2,300
post-traumatic stress disorder 1 | 45
subependymal giant cell astrocytoma 1 | 2,287
tuberculosis 1 | 1,557

Tissue

Cardiovascular System 5 | 17,958
Digestive Tract 5 | 18,473
Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Liver and Pancreas 5 | 18,136
Male tissues 5 | 17,969
Nervous System 5 | 18,561
Respiratory system 5 | 17,484
Urinary Tract 5 | 18,444
Blood and immune system 4 | 17,995
Skin and soft tissues 4 | 18,115

Target Family

Non-IDG 5 | 11,971

Grant Application

5R01DK103872-02 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Tetraspanin-31 TSPAN31 Tdark Non-IDG -0.69496 4.21 69
Putative peripheral benzodiazepine receptor-related protein TSPO Tbio Non-IDG -3.29377 2078.3 186
Cohesin subunit SA-1 STAG1 Tbio Non-IDG -2.43014 274.6 177
Urocortin UCN Tbio Non-IDG -2.73199 595.2 148
Corticoliberin CRH Tbio Non-IDG -3.72173 5615.4 346